EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The RNA ‐binding protein RBMS3 inhibits the progression of colon cancer by regulating the stability of LIMS1 mRNA

Yafei Li, Shuoshuo Wang, Guoli Li, Chunyang Gao, Zihan Cui, Mingqi Cong, Jie Hu, Minghui Zhang, Xiaoming Jin iD, Haiying Sun iD, Dan Kong

Cancer Medicine · 2024-04 · 13 (7)

DOI: 10.1002/cam4.7129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 15.04.2024. Verfasst von Yafei Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Colonic Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Scientific Research Project of Harbin Medical University, the Inner Mongolia Science and Technology Plan Project, the Natural Science Foundation of Inner Mongolia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The RNA‐binding motif single‐stranded interacting protein 3 (RBMS3) is a constituent of the RNA‐binding motif (RBM) protein family, which assumes a pivotal role in governing cellular biogenesis processes such as the cell cycle and apoptosis. Despite an abundance of studies elucidating RBMS3's divergent roles in the genesis and advancement of various tumors, its involvement in colon cancer remains enigmatic.

Methods

The present investigation employed data analysis from TCGA and GTEx to unveil that RBMS3 expression demonstrated a diminished presence in colon cancer tissues when juxtaposed with normal colon tissues. The effect of RBMS3 and LIM zinc finger domain 1 (LIMS1) on colon cancer was substantiated via animal models and cellular experiments. The connection between RBMS3 and LIM zinc finger domain 1 (LIMS1) was verified by molecular biology methods.

Results

The study conclusively ascertained that augmenting RBMS3 expression quells the proliferation, migration, and invasion of colon cancer cells. Furthermore, the inquiry unveiled a plausible mechanism through which RBMS3 impacts the expression of LIMS1 by modulating its mRNA stability. The investigation ascertained that RBMS3 inhibits the progression of colon cancer by regulating LIMS1. The inhibitory function of LIMS1 and RBMS3 is closely intertwined in colon cancer, with knocking down LIMS1 being able to rescue the inhibitory effect of RBMS3 overexpression on the functionality of colon cancer cell Conclusions The discernments delineate RBMS3 as a novel suppressor of cancer via LIMS1, thereby bestowing fresh therapeutic possibilities and illuminating the intricacies of colon cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsAnimalsApoptosisCell CycleRNA, MessengerRNA-Binding ProteinsHumansMembrane ProteinsAdaptor Proteins, Signal TransducingLIM Domain ProteinsTrans-Activators

Stichwörter der Autor:innen

LIMS1RBMS3cell proliferationcolon cancermetastasis

Substanzen

RNA, MessengerRNA-Binding ProteinsLIMS1 protein, humanMembrane ProteinsAdaptor Proteins, Signal TransducingLIM Domain ProteinsRBMS3 protein, humanTrans-Activators

Autor:innen und Institutionen

  • Department of Pathology, Harbin Medical University, Harbin, China.
  • Department of Anus and Intestine Surgery, Chifeng Municipal Hospital, Chifeng, China.
  • Department of Anatomy, Harbin Medical University, Harbin, China.
  • Central Operating Department, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Department of Oncology, Chifeng Municipal Hospital, Chifeng, China.
  • Gastrointestinal Rehabilitation Center, Beijing Rehabilitation Hospital of Capital Medical University, Beijing, China.

ORCID-Profile: Xiaoming Jin, Haiying Sun

Förderung

  • Innovative Scientific Research Project of Harbin Medical University
  • the Inner Mongolia Science and Technology Plan Project
  • the Natural Science Foundation of Inner Mongolia
  • Postdoctoral Fellowship Program of China Postdoctoral Science Foundation
  • the China Postdoctoral Science Foundation
  • Natural Science Foundation of Inner Mongolia Autonomous Region

Zitieren

APA

Li, Y., Wang, S., Li, G., Gao, C., Cui, Z., Cong, M., Hu, J., Zhang, M., Jin, X., Sun, H., & Kong, D. (2024). The RNA ‐binding protein RBMS3 inhibits the progression of colon cancer by regulating the stability of LIMS1 mRNA. Cancer Medicine, 13(7). https://doi.org/10.1002/cam4.7129

Vancouver

Li Y, Wang S, Li G, Gao C, Cui Z, Cong M, et al. The RNA ‐binding protein RBMS3 inhibits the progression of colon cancer by regulating the stability of LIMS1 mRNA. Cancer Medicine. 2024;13(7). doi:10.1002/cam4.7129

BibTeX
@article{Li2024,
  author = {Li, Yafei and Wang, Shuoshuo and Li, Guoli and Gao, Chunyang and Cui, Zihan and Cong, Mingqi and Hu, Jie and Zhang, Minghui and Jin, Xiaoming and Sun, Haiying and Kong, Dan},
  title = {The RNA ‐binding protein RBMS3 inhibits the progression of colon cancer by regulating the stability of LIMS1 mRNA},
  journal = {Cancer Medicine},
  year = {2024},
  volume = {13},
  number = {7},
  doi = {10.1002/cam4.7129}
}
Kostenlos starten →